Switching antipsychotic medications to reduce adverse event burden in schizophrenia: establishing evidence-based practice

The Journal of Clinical Psychiatry
John W NewcomerRobert W Buchanan

Abstract

The purpose of this project was to provide evidence-based guidance concerning when and how it is appropriate to undertake elective changes in antipsychotic medications in order to reduce adverse effects, with a focus on those adverse effects associated with increased long-term health risks. This project extends the results of the National Institute of Mental Health-funded 2009 Schizophrenia Patient Outcomes Research Team (PORT) psychopharmacologic treatment recommendations. The authors reviewed the literature on switching antipsychotics, focusing on randomized controlled trials published since the 2009 Schizophrenia PORT. The studies reviewed support a recommendation that an elective switch from higher to lower metabolic risk antipsychotics can produce weight and lipid benefits without significant risk of clinical deterioration. Evidence also suggests that certain antipsychotic switches may improve other adverse effects, including extrapyramidal symptoms and prolactin elevation. In deciding to make an elective change of antipsychotic medication, it is important to conduct a careful risk/benefit assessment with the patient. Before initiating a switch, patients should be educated about what to expect during the process. Studies a...Continue Reading

Citations

Apr 26, 2014·PloS One·Maarten BakMarjan Drukker
Mar 11, 2015·Early Intervention in Psychiatry·Martin StrassnigRohan Ganguli
Mar 10, 2015·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Andrea MurruEduard Vieta
Nov 8, 2016·Evidence-based Complementary and Alternative Medicine : ECAM·Jui-Fen ChengHan-Yi Ching
Sep 8, 2018·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·T Scott Stroup, Neil Gray
Oct 31, 2017·Clinical Practice and Epidemiology in Mental Health : CP & EMH·Esra YaziciAtila Erol
May 7, 2016·Journal of General Internal Medicine·Christina MangurianDean Schillinger
Jan 4, 2017·Schizophrenia Bulletin·Hiroyoshi TakeuchiGary Remington
Aug 25, 2016·Neurology and Therapy·Benedicto Crespo-FacorroJacqueline Mayoral-van Son
Jul 1, 2017·Journal of Endocrinological Investigation·A A Verhaegen, L F Van Gaal
Jul 18, 2017·The South African Journal of Psychiatry : SAJP : the Journal of the Society of Psychiatrists of South Africa·Ingrid EloffKavendren Odayar
Aug 16, 2019·Annals of General Psychiatry·Andrew GoodspeedWeston W Blakeslee
Sep 2, 2020·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Jason M Noel, Cherry W Jackson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here